… outcomes in patients initiating a new highly active antiretroviral therapy (HAART) regimen is
… -naive HIV-infected patients prescribed a new HAART regimen (3538 patients) and enrolled …

… Before a new RR/MDR treatment regimen composed of bedaquiline and linezolid can be …
drug in the treatment regimen of RR/MDR-TB given that such a regimen is widely accessible …

… composition that require special consideration when designing drug regimens: obese patients,
patients … limbs, pregnant patients, and patients undergoing ECMO or plasma exchange. …

… a de novo lack of treatment response, whereas acquired … mutated NSCLC patients who
achieve an effective response or … while they are still on the targeted therapy (Jackman et al., 2010)…

… treatment regimens … composition of treatment regimens for MDR-TB. We propose to reserve
the term ‘core drug’ for the one drug in a regimen that contributes most to relapse-free cure. …

… fluid therapy. The aim of the study was to determine whether, among patients with systemic
inflammatory response … compared with a regimen composed of more physiologic IV solutions. …

… patients, we found that despite an intensive regimen of therapy, the majority of treatment
response … where K 2 is a constant that defines the body composition and relative dose injected. …

… treatment regimens against an extensive collection of PDXs (1075 models across 15
cancer-types) has shown that tumorgrafts were able to reproduce treatment responses … …

… While treatment may be curative in the early stages of the disease, the majority of patients
… Most patients face an intensive and invasive treatment regimen comprising surgery, …

… ECF or a similar regimen, with no difference between patients with and without sarcopenia.
… composition has been observed in patients receiving a variety of different ChT regimens [35,…